Ligand price target raised to $231 from $206 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Ligand (LGND) to $231 from $206 and keeps a Buy rating on the shares. The firm cites the company’s “strong” Q3 results and continued business development activity for the target boost. The “power of the model continues to deliver the numbers,” the analyst tells investors in a research note.